Compare MasterCard Inc (MA) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
MasterCard Inc vs Zimmer Biomet Holdings Inc — how do they compare? MasterCard Inc trades at $543.13 (market cap $483.71B), while Zimmer Biomet Holdings Inc trades at $89.66 (market cap $17.36B). The key difference: MasterCard Inc is far larger — about 27.9× Zimmer Biomet Holdings Inc's market cap, and Zimmer Biomet Holdings Inc pays the higher dividend (1.07%). Which is the better fit depends on your goals.
| MA | ZBH | |
|---|---|---|
Market Cap | $483.71B | $17.36B |
Volume | 4,635,698 | — |
Sector | Consumer Cyclical | Health |
52-Week High | $598.96 | $107.71 |
52-Week Low | $471.55 | $79.58 |
Enterprise Value | $494.45B | $24.40B |
Dividend Yield | 0.64% | 1.07% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Mastercard (MA) trades at $543.19, down 0.08% on the day, with a bullish technical outlook supported by moving averages and strong institutional buying. The company reported robust earnings beats in recent quarters, with Q1 2026 EPS of $4.60 exceeding the $4.41 estimate. Revenue grew to $32.79 billion in 2025, while net income margin remained high at 45.88%. Analysts maintain a strong buy consensus with a $634.27 price target, reflecting confidence in continued payment volume growth and digital expansion initiatives.
The stock presents a compelling growth opportunity given its consistent profitability, expanding cash flows, and leadership in digital payments. Key risks include competitive disruption from stablecoins and regulatory scrutiny. With zero sell ratings and 79% buy recommendations, Wall Street sentiment is overwhelmingly positive, though investors should monitor execution on AI and emerging market strategies against valuation multiples above sector averages.
Zimmer Biomet (ZBH) trades at $89.74, down 1.51% on the day, with a bullish technical signal from moving averages and a consensus price target of $97.67. The company reported revenue of $8.23B in 2025, with net income of $705.10M and a net margin of 8.56%. Recent developments include expansion in Asia Pacific and a planned $1 billion share repurchase program, while Q2 2026 earnings are anticipated on August 5, 2026.
ZBH presents a mixed outlook with strong profitability margins and recent earnings beats offset by declining net income margins and rising debt levels. The stock offers potential upside to analyst targets but faces execution risks in competitive medical markets and macroeconomic pressures on healthcare spending.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About MasterCard Inc
Mastercard Incorporated provides financial transaction processing services. The Company offers payment processing services for credit and debit cards, electronic cash, automated teller machines, and travelers checks. Mastercard serves customers worldwide.
Read more on MA →About Zimmer Biomet Holdings Inc
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →
